Oxford scientist set for £15m payday in Vaccitech flotation

Professor Sarah Gilbert, the Oxford scientist behind Astrazeneca’s coronavirus jab, is set to land a payday of as much as $20m (£15m) as her vaccine start-up prepares for its stock market debut.

Gilbert is understood to be sitting on millions of dollars worth of shares in biotech firm Vaccitech, which is expected to list in an initial public offering (IPO) in New York later this year.

Read more: UK regulator recommends alternative to Astrazeneca vaccine for under-30s

Gilbert established Vaccitech in 2016 together with fellow university professor Andrew Hill. The firm has played a crucial role in the development of the Astrazeneca vaccine, which the Anglo-Swedish company has pledged to sell on a n...